AtaiBeckley (ATAI) Interest Expenses (2022 - 2025)

AtaiBeckley (ATAI) recorded quarterly Interest Expenses of $900000.0 in Q1 2025.

AtaiBeckley (ATAI) Interest Expenses (2022 - 2025) Analysis & Trends

AtaiBeckley's Interest Expenses history runs 1 years deep, the most recent figure standing at $900000.0 for Q1 2025.

  • Interest Expenses for Q2 2025 came in at $264000.0, down 62.39% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.1 million (down 26.09% YoY), and the FY2024 annual result was $3.1 million, up 17.62% from the prior year.
  • Interest Expenses came in at $264000.0 for Q2 2025 at AtaiBeckley, down from $900000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $952000.0 in Q4 2024 to a low of $264000.0 in Q2 2025.
  • The 4-year median for Interest Expenses is $691000.0 (2023), against an average of $715272.7.
  • Across the five-year window, Interest Expenses soared 37.77% in 2024 and slumped 62.39% in 2025, its largest moves.
  • AtaiBeckley's Interest Expenses stood at $923000.0 in 2022, then dropped by 25.14% to $691000.0 in 2023, then jumped by 37.77% to $952000.0 in 2024, then tumbled by 72.27% to $264000.0 in 2025.
  • The last three Interest Expenses figures came in at $264000.0 (Q2 2025), $900000.0 (Q1 2025), and $952000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -5.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -332,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 61,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -2,753.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -5.58 Mn
10 AtaiBeckley 1.45 Bn 1.45 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 264,000.00
Jun 30, 2025 264,000.00
Mar 31, 2025 900,000.00
Mar 31, 2025 900,000.00
Mar 31, 2025 900,000.00
Mar 31, 2025 900,000.00
Dec 31, 2024 952,000.00
Dec 31, 2024 952,000.00
Sep 30, 2024 783,000.00
Sep 30, 2024 783,000.00
Jun 30, 2024 702,000.00
Jun 30, 2024 702,000.00
Mar 31, 2024 687,000.00
Mar 31, 2024 687,000.00
Dec 31, 2023 691,000.00
Dec 31, 2023 691,000.00
Sep 30, 2023 686,000.00
Sep 30, 2023 686,000.00
Jun 30, 2023 658,000.00
Jun 30, 2023 658,000.00